[Immunoprophylaxis of viral hepatitis].
Viral hepatitis still seems to be an important epidemiological and clinical problem. The most common source of viral hepatotropic infection is the health care service in Poland. Significant decrease in the frequency of newly diagnosed cases of acute hepatitis B were observed during the last decade. Introduction of anti-hepatitis B vaccination combined with improvement of socioeconomical status have had a significantly influenced epidemiological status of HBV infection. There is still lack of immunoprophylaxis for HCV infection. Current rules of active and passive prophylaxis for HBV and HCV infections were discussed in this paper.
Biesiada
Grazyna
G
Katedra i Klinika Chorób Zakaźnych, Collegium Medicum, Uniwersytetu Jagiellońskiego w Krakowie.
Mach
Tomasz
T
D018562:Disease Transmission, Infectious / Q000517:prevention & control*; D006509:Hepatitis B / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control* / Q000635:transmission*; D006510:Hepatitis B Antibodies / Q000097:blood; D017325:Hepatitis B Vaccines / Q000627:therapeutic use; D006526:Hepatitis C / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control* / Q000635:transmission*; D018937:Hepatitis C Antibodies / Q000097:blood; D006801:Humans; D007116:Immunization, Passive; D011044:Poland / Q000453:epidemiology; D015995:Prevalence; D012307:Risk Factors; D012959:Socioeconomic Factors; D016635:Universal Precautions; D014761:Viral Hepatitis Vaccines / Q000627:therapeutic use*
D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines; D018937:Hepatitis C Antibodies; D014761:Viral Hepatitis Vaccines